Scholars Central

Conference abstractPublished 5 Oct 2015

A retrospective analysis of frequency of ALK gene rearrangement in Saudi lung patients

Authors: Fouad Hassan Al-Dayel, Hamad Al Husaini, Shamayel Mohammed, Asma Tulbah, Khawla Al Kuraya

King Faisal Specialist Hospital and Research Centre, Saudi Arabia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Lung carcinoma represents 2.6% of cancer seen at King Faisal Specialist Hospital and Research Centre (KFSH & RC) and 4.5% of cancers in Saudi Arabia as per Saudi Cancer Registry. EML4-ALK re-arrangements are found to play an oncogenic driver role in lung adenocarcinoma tumor genesis in 3-6% of cases. ALK gene rearrangement testing can identify patients with adenocarcinoma who are sensitive to ALK kinase inhibitors. However, no data are available on the prevalence of ALK rearrangements changes in Middle Eastern population. Therefore, we carried out this study to evaluate the prevalence of ALK gene rearrangements in lung adenocarcinoma of Saudi patients. Methods: ALK gene rearrangements were studied using fluorescence in situ hybridization (FISH) on 198 adeno-carcinoma samples utilizing tissue microarray format. ALK gene rearrangements tested using break-apart probes from Vysis. Results: One hundred ninety eight (198) lung adenocarcinoma cases were evaluated. Eleven (11) cases exhibited ALK gene rearrangement (5.5%). Seven (7) of these cases were metastatic lung adenocarcinoma (stage IV). Mean age of the patient is 51 years (21-79 years). History of smoking was available on only four (4) cases (2 smokers and 2 non-smokers). All cases were moderately to poorly differentiated adenocarcinoma. None of our cases showed signet cells or abundant intracellular mucin. Conclusion: The findings of this retrospective study show that the incidence of ALK gene rearrangements positive adenocarcinoma in Saudi patients is 5.5%. This is similar to the published data.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Fouad Hassan Al-Dayel”
  • BylineArticles whose byline prints “Hamad Al Husaini”
  • BylineArticles whose byline prints “Shamayel Mohammed”
  • BylineArticles whose byline prints “Asma Tulbah”
  • BylineArticles whose byline prints “Khawla Al Kuraya”